受容体シグナル伝達阻害剤を含む脳梗塞治療用医薬品組成物
- 专利权人:
- 国立大学法人;新潟大学
- 发明人:
- 下畑 享良
- 申请号：
- JP2010124382
- 公开号：
- JP5823672B2
- 申请日:
- 2010.05.31
- 申请国别(地区):
- JP
- 年份:
- 2015
- 代理人:
- 摘要：
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral infarction, administrable even to patients after cerebral infarction acute stage passage.
SOLUTION: The therapeutic pharmaceutical composition for the treatment of cerebral infarction comprises a thrombolytic agent and a vascular endothelial growth factor (VEGF) receptor-signaling inhibitor. The therapeutic pharmaceutical composition for the treatment of cerebral infarction is, if necessary, administered into patients after cerebral infarction acute stage passage. The therapeutic pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains a tissue type plasminogen-activator (t-PA) or its derivative.
COPYRIGHT: (C)2011,JPO&INPIT
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
- INDANE-AMINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
- New indole compounds as selective andro progestogen receptor modulators (SARMS)
- שימוש בקולטן fc גאמא מסיסיי ותכשירים המכילים אותו לטיפול במחלת בולוס אוטואימונית
- HETEROCYCYL-SUBSTITUTED-ALKYLAMINOPHENYL DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
